Acumen Pharmaceuticals, Inc. Common Stock
ABOS Real Time Price USDRecent trades of ABOS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ABOS's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ABOS Revenue by Segment or Geography
New patents grants
-
Patent Title: Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 Apr. 26, 2016
-
Patent Title: Antibodies, kit and method for detecting amyloid beta oligomers Apr. 12, 2016
-
Patent Title: Addl receptor polypeptides, polynucleotides and host cells for recombinant production Dec. 22, 2015
-
Patent Title: Antibodies, kit and method for detecting amyloid beta oligomers Nov. 03, 2015
-
Patent Title: Methods of modifying amyloid β oligomers using non-peptidic compounds Apr. 14, 2015
-
Patent Title: Methods of restoring cognitive ability using non-peptidic compounds Feb. 24, 2015
-
Patent Title: Compositions and methods for the enhancement of soluble amyloid beta oligomer (addl) uptake and clearance Jun. 21, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ABOS
Number of mentions of ABOS in WallStreetBets Daily Discussion
Recent picks made for ABOS stock on CNBC
ETFs with the largest estimated holdings in ABOS
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ABOS stock?
- Who owns the most shares of $ABOS stock?
- What funds own $ABOS stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ABOS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.